Abstract:Summary Background Trigeminal neuralgia (TN) is characterized by repeated paroxysmal attacks of severe facial pain usually lasting 1-3 minutes. Lifetime prevalence is ca.3 per 1,000, more common in women, and with onset generally in middle age. Medications usually provide relief in the early stages of the disorder, but for many patients, severe drug side effects emerge and medically intractable pain returns, sometimes lasting for life. Some patients present with paroxysmal pain predominantly while others also experience substantial concomitant constant facial pain. Some patients have a history of a blood vessel compressing and damaging their trigeminal nerve (neurovascular compression, NVC). For these classical cases, surgery often provides complete or substantial pain relief for many years. Idiopathic cases without NVC or any other apparent cause also occur. NVC was previously observed to be less frequent in females who had early age of onset and these patients may constitute a unique subgroup. Our aim was to evaluate the role of inherited genetic variation in the aetiology of TN in patient subgroups based on age of onset, presence of NVC and sex. Methods To maximize aetiological homogeneity, only patients with predominantly paroxysmal pain and minimal concomitant continuous pain were included in the analysis. Conditions known to cause secondary TN such as tumors or multiple sclerosis were excluded. The GWAS analysis was based on 626 TN patients and 827 Control subjects of European ancestry recruited in Canada, the UK, and US. A Genome-Wide Association Study (GWAS) analysis was performed using Affymetrix Precision Medicine arrays yielding 7,781,254 biallelic DNA variants available after Quality Control (QC) and imputation. Rare damaging mutations in genes with functions relevant to the biology of TN were identified in Whole Genome Sequencing (WGS) genomic DNA of 100 patients using a novel strategy based on overlap of symptoms of TN with symptoms of known genetic disorders. Findings The GWAS analysis revealed associations at eight genome locations including near LRP1B (P-value 6.3 X 10-15), a gene important for repair of myelin sheath injury that has been previously proposed as a target for the treatment of neuropathic pain. Associations were also found for the potassium channel gene KCNK10, and for CHL1, CUX1, SGMS1 and ZNF804B genes, all genes with neural functions potentially relevant to the aetiology of TN. In addition, high-risk genotypes at the CUX1 and KCNK10 genes exhibit significant interactions with sex and the presence or absence of NVC (P-values 0.005 and 0.017, respectively). Whole genome sequencing of 100 TN patients revealed mutations in ion channel genes TRPM4 (six patients), SCN10A and SCNN1B (five patients), CACNA1F, CACNA1S and SCN5A (four patients) and CACNA1H, SCN2A and SCN9A (three patients). Female patients with onset prior to age 46 had more mutated genes with myelin-related functions (P-value 0.004) and associated with epilepsy or seizure (P-value 0.03) than older onset females and males of any onset age. Interpretation Risk of TN in patients presenting with paroxysmal pain only is associated with both common genetic variants and with rare mutations. Some high-risk genotypes have significant interactions with sex and NVC. Evidence of this heterogeneous genetic aetiology should be considered when evaluating novel therapies.

Comparative evaluation of lyophilized freeze dried platelet derived preparation with calcium hydroxide as pulpotomy agents in primary molars.

Electrophysiological characterization of a CaV3.1 calcium channel mutation linked to trigeminal neuralgia

Electrophysiological and computational analysis of Cav3.2 channel variants associated with familial trigeminal neuralgia

Mechanistic contribution of CaV3.2 calcium channels to trigeminal neuralgia pathophysiology not clarified

A CACNA1A variant associated with trigeminal neuralgia alters the gating of Cav2.1 channels

Trigeminal neuropathic pain is alleviated by inhibition of Cav3.3 T-type calcium channels in mice

Tailor-designed polyphilic promotors for stabilizing dispersions of carbon nanotubes in liquid crystals.

The expression of voltage-gated sodium channels in trigeminal nerve following chronic constriction injury in rats

P2X receptors and trigeminal neuralgia

Increased Expression of Ca(V)3.2 T-type Calcium Channels in Damaged DRG Neurons Contributes to Neuropathic Pain in Rats with Spared Nerve Injury

Role of common and rare genetic variants in the aetiology of trigeminal neuralgia

A Novel Pathophysiological Mechanism Contributing to Trigeminal Neuralgia

Kv4.3 Channel Dysfunction Contributes to Trigeminal Neuropathic Pain Manifested with Orofacial Cold Hypersensitivity in Rats

Exome sequencing implicates impaired GABA signaling and neuronal ion 1 transport in trigeminal neuralgia

Molecular mechanisms of trigeminal neuralgia: A systematic review

Calcium Channel 21 Subunit Mediates Secondary Orofacial Hyperalgesia Through PKC-TRPA1/Gap Junction Signaling

Familial trigeminal neuralgia – a systematic clinical study with a genomic screen of the neuronal electrogenisome

The T-Type Calcium Channel Cav3.2 in Somatostatin Interneurons in Spinal Dorsal Horn Participates in Mechanosensation and Mechanical Allodynia in Mice

Nav1.8 in small dorsal root ganglion neurons contributes to vincristine-induced mechanical allodynia

Calcium Channel Α2δ1 Subunit Mediates Secondary Orofacial Hyperalgesia Through PKC-TRPA1/Gap Junction Signaling.

Connexin 43 Contributes to Temporomandibular Joint Inflammation Induced-Hypernociception Via Sodium Channel 1.7 in Trigeminal Ganglion.